Additionally, this compound modulates key MAPK signaling genes, such as FGFR2, EGFR, K-RAS, and c-MYC, and tumor suppressors, such as DUSP6 and Fos, as well as the cell cycle regulators CCNB1 and CCNB1IP1. Here, KRAS is linked to neoplasm.